CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 61 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,886 | -85.3% | 49,512 | -74.1% | 0.00% | – |
| Q2 2023 | $229,834 | -69.5% | 191,528 | -70.2% | 0.00% | – |
| Q1 2023 | $752,674 | +81.0% | 643,311 | +22.2% | 0.00% | – |
| Q4 2022 | $415,768 | +49.6% | 526,288 | +128.6% | 0.00% | – |
| Q3 2022 | $278,000 | -10.0% | 230,264 | -31.5% | 0.00% | – |
| Q2 2022 | $309,000 | -49.9% | 335,987 | -2.5% | 0.00% | – |
| Q1 2022 | $617,000 | -68.5% | 344,563 | -72.9% | 0.00% | – |
| Q4 2021 | $1,958,000 | +3.7% | 1,271,740 | +36.7% | 0.00% | – |
| Q3 2021 | $1,888,000 | +71.2% | 930,098 | +193.1% | 0.00% | – |
| Q2 2021 | $1,103,000 | +530.3% | 317,321 | +223.6% | 0.00% | – |
| Q1 2021 | $175,000 | +600.0% | 98,067 | +304.1% | 0.00% | – |
| Q4 2019 | $25,000 | – | 24,268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 188,796 | $291,000 | 0.08% |
| Horst & Graben Wealth Management LLC | 75,722 | $117,000 | 0.03% |
| Alpine Global Management, LLC | 83,475 | $129,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $77,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 30,863 | $48,000 | 0.01% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 49,075 | $76,000 | 0.00% |
| Alberta Investment Management Corp | 172,185 | $265,000 | 0.00% |
| Syverson Strege & Co | 2,145 | $3,000 | 0.00% |
| HighTower Advisors, LLC | 170,623 | $263,000 | 0.00% |
| HRT FINANCIAL LP | 90,871 | $139,000 | 0.00% |